GT200400183A - DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTS - Google Patents
DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTSInfo
- Publication number
- GT200400183A GT200400183A GT200400183A GT200400183A GT200400183A GT 200400183 A GT200400183 A GT 200400183A GT 200400183 A GT200400183 A GT 200400183A GT 200400183 A GT200400183 A GT 200400183A GT 200400183 A GT200400183 A GT 200400183A
- Authority
- GT
- Guatemala
- Prior art keywords
- azithromycin
- dosage forms
- side effects
- reduced side
- effective amount
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
LA PRESENTE INVENCIÒN SE REFIERE A UNA FORMA DE DOSIFICACIÒN ORAL QUE COMPRENDE AZITROMICINA Y UNA CANTIDAD EFICAZ DE UN AGENTE ALCALINIZANTE. PREFERIBLEMENTE, DICHA FORMA DE DOSIFICACIÒN ORAL COMPRENDE UNA CANTIDAD EFICAZ DE UN AGENTE ALCALINIZANTE Y UN MULTIPARTICULADO DE AZITROMICINA.THE PRESENT INVENTION REFERS TO AN ORAL DOSAGE FORM THAT INCLUDES AZITHROMYCIN AND AN EFFECTIVE AMOUNT OF AN ALKALINIZING AGENT. PREFERIBLY, SUCH ORAL DOSAGE FORM INCLUDES AN EFFECTIVE AMOUNT OF AN ALKALINIZING AGENT AND A MULTIPARTICULATE OF AZITHROMYCIN.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52708403P | 2003-12-04 | 2003-12-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200400183A true GT200400183A (en) | 2005-10-24 |
Family
ID=34699855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200400183A GT200400183A (en) | 2003-12-04 | 2004-09-16 | DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTS |
Country Status (8)
Country | Link |
---|---|
CN (1) | CN1697648B (en) |
AP (1) | AP2218A (en) |
AU (1) | AU2004216676B2 (en) |
EC (1) | ECSP045351A (en) |
GT (1) | GT200400183A (en) |
TN (1) | TNSN05319A1 (en) |
UA (1) | UA78793C2 (en) |
ZA (1) | ZA200408075B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA200805793B (en) * | 2005-12-22 | 2009-11-25 | Otsuka Pharma Co Ltd | Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol |
CN103054813A (en) * | 2012-12-31 | 2013-04-24 | 广东先强药业有限公司 | Azithromycin oral sustained-release dry suspension and preparation method thereof |
CN104177457A (en) * | 2013-05-23 | 2014-12-03 | 长春海悦药业有限公司 | Azithromycin drug raw material, and preparation and application thereof |
CN107427494A (en) * | 2015-03-10 | 2017-12-01 | 卢莫斯制药公司 | The micro- supensoid agent of circular muscle acid |
CA3051914A1 (en) * | 2017-02-02 | 2018-08-09 | Mcmaster University | Bicarbonate as a potentiator for antimicrobial agents |
CN114213484A (en) * | 2021-12-21 | 2022-03-22 | 河北远征药业有限公司 | Tildipirosin 1, 2-propylene glycol solvent compound and preparation method thereof |
CN115212173A (en) * | 2022-07-11 | 2022-10-21 | 上海现代药物制剂工程研究中心有限公司 | Ambroxol hydrochloride spherical sustained-release particles, preparation method and application |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW271400B (en) * | 1992-07-30 | 1996-03-01 | Pfizer | |
US5605889A (en) * | 1994-04-29 | 1997-02-25 | Pfizer Inc. | Method of administering azithromycin |
CN1123279A (en) * | 1995-06-15 | 1996-05-29 | 沈家祥 | Azithmycin water-soluble salt, injection thereof and their usage |
NZ534234A (en) * | 2002-02-01 | 2007-05-31 | Pfizer Prod Inc | Dry granulated formulations of non-dihydrate form of azithromycin |
-
2004
- 2004-05-14 AU AU2004216676A patent/AU2004216676B2/en not_active Expired
- 2004-05-14 AP APAP/P/2004/003145A patent/AP2218A/en active
- 2004-05-14 UA UA20041210181A patent/UA78793C2/en unknown
- 2004-05-14 CN CN200480000209.2A patent/CN1697648B/en not_active Expired - Lifetime
- 2004-09-16 GT GT200400183A patent/GT200400183A/en unknown
- 2004-10-06 ZA ZA200408075A patent/ZA200408075B/en unknown
- 2004-10-08 EC ECSP045351 patent/ECSP045351A/en unknown
-
2005
- 2005-12-14 TN TNP2005000319A patent/TNSN05319A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1697648B (en) | 2010-06-23 |
AU2004216676A1 (en) | 2005-06-23 |
AU2004216676B2 (en) | 2011-06-16 |
ZA200408075B (en) | 2007-01-31 |
AP2004003145A0 (en) | 2004-09-30 |
ECSP045351A (en) | 2005-01-28 |
TNSN05319A1 (en) | 2007-07-10 |
UA78793C2 (en) | 2007-04-25 |
CN1697648A (en) | 2005-11-16 |
AP2218A (en) | 2011-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY28509A1 (en) | DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTS | |
DOP2019000185A (en) | A SOLID PHARMACEUTICAL DOSAGE FORMULATION | |
CL2004000927A1 (en) | TRANSDERMAL DOSAGE FORM THAT INCLUDES AN ACTIVE AGENT, A NEXT SURFACE AND A DISTAL SURFACE. | |
JP2004210767A5 (en) | ||
RS50660B (en) | Dihydrotetrabenazines and pharmaceutical compositions containing them | |
HN2002000142A (en) | SHAMPOOS WITH BEHENYL ALCOHOL | |
ES2539945T3 (en) | Oral formulations of opioid agonists resistant to improper manipulations | |
BR0304291B1 (en) | sanitary napkin. | |
ECSP055888A (en) | DERIVATIVES OF ARIL-QUINAZOLIN / ARIL-2-AMINO-FENIL METANONA THAT PROMOTE THE RELEASE OF PARTIROID HORMONE. | |
ECSP078057A (en) | FORMULATIONS OF CONJUGATED ESTROGENS AND BAZEDOXIFEN | |
TW200733954A (en) | Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same | |
GT200400183A (en) | DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTS | |
DK1713438T3 (en) | Medical soap | |
NO20040857L (en) | New oral prolonged release dosage form. | |
EA200600066A1 (en) | Tamsulozine-containing core coated with polyvinylpyrrolidone or polyvinyl acetate | |
NO20040966D0 (en) | Oral vaccines. | |
GT200600403A (en) | PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS | |
GEP20084546B (en) | Novel association consisting of an anti-atherothrombotic agent and of platelet antiaggregating agent | |
NO20031239L (en) | 1-amino-alkylcyclohexanes as trypanocidal agents | |
MXPA03001857A (en) | MEDICINAL COMPOSITIONS. | |
AR027152A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COGNITIVE CEREBROVASCULAR DISEASE. | |
UY27083A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COGNOSTIC CEREBROVASCULAR DISEASE | |
RU2000116332A (en) | ANThelmintic | |
ES1050190Y (en) | ELECTRICAL GENERATOR IN THE FORM OF A BALANCE UNBALANCED BY A BALL THAT TRAVELS A CHANNEL ABOVE THE BALANCE. | |
BR0102216B1 (en) | Improvements to the integrated valve discharge valve. |